HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
16 hedge funds and large institutions have $338K invested in Hepion Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$128K | |
| 2 | +$19.6K | |
| 3 | +$11.1K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.67K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$703 |
Top Sellers
| 1 | -$526K | |
| 2 | -$24.6K | |
| 3 | -$15K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$11K |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$90 |